MediPharm Labs (MEDIF) announced that independent proxy voting and corporate governance advisory firm Glass, Lewis & Co. published a report on June 12 recommending that MediPharm shareholders vote the GREEN Proxy or voting instruction form FOR the Company’s nominees for the Board of Directors at the upcoming Annual and Special Meeting of Shareholders on June 16. Glass Lewis is the second independent proxy advisory firm to recommend voting for the Company’s nominees for the Board, following a similar recommendation issued by Institutional Shareholder Services on May 30.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEDIF:
- MediPharm Labs Advocates for Current Strategy Amid Shareholder Vote
- MediPharm Labs Wins Court Dismissal, Ensures Fair Shareholder Meeting
- Apollo releases investor presentation on plan for Medipharm Labs
- MediPharm Labs Sells Hope Facility and Expands EU GMP Cultivation
- Medipharm Labs closes sale of Hope facility, plans to expand Napanee capacity